The potential of CRISPR technology
Our portfolio for CRISPR genome scissors is used in order to understand the functions of individual genes and their interaction in a cell. These findings help to develop new therapies.
Our competence in genome editing
In recent years, CRISPR biomolecules (Clustered Regularly Interspaced Short Palindromic Repeats) were discovered and developed into a facile genome-editing technology. Similar to a word processing program, which finds, deletes or replaces words or letters, these RNA-protein complexes (CRISPR) search for certain DNA sequences in a cell, cut them and allow the cell to paste in new DNA information. Thanks to our long-standing experience with CRISPR technology, we now offer researchers a broad portfolio of genomic scissors.
Correcting genes that cause disease
A lot has happened in the fields of medical research and biotechnology since the first reports of success in deciphering the human genome. Scientists have long been working on identifying genes that are associated, for example, with cancer. And now they have a path forward: to specifically modify the sequences of these genes using genomic scissors. The results to date are very promising. However, it will still take some time before genome editing can be routinely used in medical therapy.
New paths in disease research
Yet treating diseases by the repair of gene defects is only one of the possible fields of application for CRISPR technology. It is also used in basic and pharmaceutical research. By knocking out genes, scientists learn what functions these genes have and how diseases develop. Our CRISPR tools are used, for example, to create model systems for diseases – these systems provide important new findings for developing and testing novel medicines.
We recognize the potential benefits of genome editing and its breakthrough therapeutic promise, and we continue to pursue our research with careful consideration of ethical and legal standards.
Reliable production of active ingredients
Biopharmaceutical production also benefits from our Life Science portfolio: We offer cell lines for the production of biopharmaceuticals, for example of therapeutic antibodies. These cells have been modified by means of genome-editing technology in such a way that they are less susceptible to contamination in the bioreactor, thus making the production of active ingredients more reliable and more stable.
Our CRISPR portfolio
Our Life Science business offers a wide selection of products for genome-editing – for research and production. Here, scientists trust in our long-standing expertise in CRISPR technology. Please visit our website for more information.
Work With Us
Our Professionals Make a Difference!
When great minds get together, they inspire each other. Our collaborative culture proves it. By working a better way—sharing ideas, voicing opinions, giving feedback and lending support—we get better results.View All Jobs